• JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
 
  Bookmark and Share
 
 
Master's Dissertation
DOI
https://doi.org/10.11606/D.42.2013.tde-18032014-151145
Document
Author
Full name
Carla Sandrina Rendall Moreira Sá
Institute/School/College
Knowledge Area
Date of Defense
Published
São Paulo, 2013
Supervisor
Committee
Câmara, Niels Olsen Saraiva (President)
Maugeri, Ieda Maria Longo
Pontillo, Alessandra
Title in Portuguese
Estudo da participação dos receptores do tipo Toll-2 e Toll-4 e da molécula adaptadora MyD88 no desenvolvimento do diabetes auto-imune experimental.
Keywords in Portuguese
Diabetes mellitus
Células cultivadas de tumor
Citocinas
Doenças auto-imunes
Inflamação
Linfócitos
Abstract in Portuguese
O diabetes mellitus tipo 1 (DMT1) é uma doença autoimune caracterizada pela destruição das células b pancreáticas, por citocinas (IFN-g, IL-1b, e TNF-a) produzidas por macrófagos e linfócitos Th1. A participação de TLRs no desenvolvimento desta doença tem sido demonstrada, porém os mecanismos envolvidos são poucos elucidados. Neste trabalho avaliamos o papel de TLR-2, TLR-4 e molécula adaptadora MyD88 no desenvolvimento do DMT1 experimental induzido por múltiplas doses de estreptozotocina. Foi observada maior severidade do DMT1 em animais TLR-2 KO, elevada glicemia e acentuada perda de peso. Um maior infiltrado celular inflamatório, aumento da expressão de bax, caspase-3 e diminuição no número de ilhotas foram observados no grupo de animais TLR-2 KO. Interessantemente, uma diminuição significante na frequência de células T reguladoras foi verificada no baço dos animais TLR-2 KO diabéticos. A deficiência do TLR-2 resultou no desenvolvimento exacerbado do DMT1, sugerindo um importante papel dos TLR-2 na modulação da resposta imune desenvolvida nesta doença.
Title in English
The role of TLR-2, TLR-4 and MyD88 in the development of experimental autoimmune diabetes.
Keywords in English
Diabetes mellitus
Autoimmune diseases
Cytokines
Inflammation
Lymphocytes
Tumor cells grown
Abstract in English
Type 1 diabetes (T1D) is an autoimmune disease characterized by pancreatic beta cell destruction by activated macrophages and Th1 lymphocytes. The role of TLRs has been demonstrated in this disease, however the mechanisms involved in this process have not yet been fully explained. We evaluated the role of TLR-2, TLR-4 and MyD88 adaptor molecule in the development of experimental autoimmune diabetes induced by multiple low-doses of streptozotocin in C57Bl/6 mice. TDM1 was more severe in TLR-2 KO mice, with higher blood glucose levels and weight loss. Increased cellular infiltrate, bax and caspase-3 expression was detected in the pancreatic islets of the diabetic TLR-2 KO group suggesting a greater destruction of pancreatic cells. Interestingly, a decreased number regulatory T cells was observed in the spleen of diabetic TLR-2 KO animals. Hence, TLR-2 receptor deficiency resulted in exacerbated development of experimental autoimmune diabetes, thereby suggesting an important role for this receptor in the modulation of the immune response developed in this disease.
 
WARNING - Viewing this document is conditioned on your acceptance of the following terms of use:
This document is only for private use for research and teaching activities. Reproduction for commercial use is forbidden. This rights cover the whole data about this document as well as its contents. Any uses or copies of this document in whole or in part must include the author's name.
Publishing Date
2014-03-29
 
WARNING: Learn what derived works are clicking here.
All rights of the thesis/dissertation are from the authors
CeTI-SC/STI
Digital Library of Theses and Dissertations of USP. Copyright © 2001-2024. All rights reserved.